Examines IL-15's effect on NK-like activation in senescent CD8+ T cells, suggesting potential therapies for aging-related immune issues.
Introduction IL-15 can stimulate CD8+ memory T (Tm) cells to exert NKG2D-mediated NK-like cytotoxicity in a TCR-independent manner, which can contribute to immunopathological host injury during viral infections. However, it has not been fully elucidated if senescent status of CD8+ Tm cells determines the degree of IL-15—induced NK-like activation. Here, we examined IL-15 responsiveness of replicative-senescent CD57+CD8+ Tm cells compared to CD57-CD8+ Tm cells and investigated the underlying molecular mechanism. Methods We obtained PBMCs from healthy donors (20-74 years) and analyzed CD57+CD8+ and CD57-CD8+ Tm cells by flow cytometry and bulk RNA-seq following ex vivo IL-15 stimulation. In addition, we performed single nucleus-multiome analysis (snRNA/ATAC-seq) of CD57+CD8+ and CD57-CD8+ Tm cells. We further analyzed single-cell transcriptomes of bystander CD8+ T cells identified with dCODE MHC-I multimers from PBMCs of patients with acute HAV infection. Results We demonstrated that senescent CD57+CD8+ Tm cells exhibit augmented IL-15—induced NK-like activation compared to non-senescent CD57-CD8+ Tm cells. The degree of IL-15—induced NK-like cytotoxicity was correlated with age and the proportion of CD57+CD8+ Tm cells. Furthermore, CD57+CD8+ Tm cells exhibited stronger NK-like activation than CD57- counterparts in patients with acute HAV infection, where the NK-like bystander activation of memory CD8+ T cells is well-exemplified. Notably, CD57+CD8+ Tm cells exhibited upregulation of Aiolos, known as a key regulator of AP-1 that is critical for IL-15—induced NK-like activation of CD8+ Tm cells. Conclusion Our findings reveal a mechanism by which augmented IL-15—induced NK-like activation of senescent CD57+CD8+ Tm cells is associated with enhanced bystander activation of CD8+ T cells in the elderly, providing insights for novel molecular targets for the treatment of aging-associated immunopathology. Funding Source n/a Topic Categories Immune Response Regulation: Cellular Mechanisms (IRC)
No takes yet. Share an insight, caveat, or question.
Kweon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: